Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities

スポンサーリンク

概要

• 論文の詳細を見る
• 1995-12-30

著者

• Tamura T

  Division Of Internal Medicine National Cancer Center Hospital

• Saijo N

  Division Of Internal Medicine National Cancer Center Hospital East

• Saijo Nagahiro

  国立医薬品食品衛生研究所

• Saijo N

  Medical Oncology National Cancer Center Hospital

• TAMURA Tomohide

  Division of Internal Medicine, National Cancer Center Hospital

• Tamura Tomohide

  国立がんセンター中央病院 腫瘍内科

• Tamura T

  National Cancer Center Hospital Tokyo

• Tamura Tomohide

  Medical Oncology Division National Cancer Center Hospital

• NISHIWAKI Yutaka

  Division of Thoracic Oncology, National Cancer Center Hospital East

• Nishiwaki Y

  Division Of Thoracic Oncology National Cancer Center Hospital East

• Nishiwaki Yutaka

  Division Of Thoracic Oncology National Cancer Center Hospital East

• Tagawa Toshiaki

  国立がんセンター中央病院 消化器内科

• Yoshida Shigeaki

  国立がんセンター東病院 消化管内科

• SASAKI Yasutsuna

  Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East

• Saijo Nagahiro

  Pharmacology Division, National Cancer Center Research Institute

• Saijo Nagahiro

  Pharmacology Division National Cancer Center Research Institute

• Tamura Tomohide

  Division Of Internal Medicine National Cancer Center Hospital

• Sasaki Yasutsuna

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Nakaya Y

  Division Of Thoracic Oncology National Cancer Center Hospital East

• Sasaki Yasutsuna

  Division Of Hematology And Oncology National Cancer Center Hospital East

関連論文

• Clinical Importance of Adherence to Treatment With Eicosapentaenoic Acid by Patients With Hypercholesterolemia
• Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy : Long-Term Efficacy and Safety in Japanese Patients With Hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a P
• Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
• Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences
• PE-403 sLR11, an Enhancer of Intimal Smooth Muscle Cell Migration, Inhibits Fat Accumulation in Mice as a Novel Adipogenesis Regulator(PE068,Obesity/SAS 2 (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
• Incremental Effects of Eicosapentaenoic Acid on Cardiovascular Events in Statin-Treated Patients With Coronary Artery Disease : Secondary Prevention Analysis From JELIS
• FRS-059 Long-term Probucol Treatment Prevents Secondary Cardiovascular Events : A Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan(FRS12,New Approaches to Atherosclerosis Research (IHD),Featured Research Session (English),
• The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
• Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events : a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
• 4 Effects of EPA on coronary artery disease in patients with gluco-metabolism derangement : JELIS subgroup analysis(Late Breaking Clinical Trials II,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• 4 Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors : Sub-analysis of primary prevention cases from JELIS(Late Breaking Clinical Trials I,Special Program,The 72nd Annual Scientific Meeting of the Japanes
• 3 Effectiveness of eicosapentaenoic acid in preventing coronary artery disease : Secondary prevention strata from JELIS.(Late Breaking Clinical Trials I,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Polymorphisms of Apolipoprotein E and Methylenetetrahydrofolate Reductase in the Japanese Population
• Association of SLC6A9 Gene Variants with Human Essential Hypertension
• LACK OF MODIFYING EFFECTS OF EUGENOL ON DEVELOPMENT OF LUNG PROLIFERATIVE LESIONS INDUCED BY URETHANE IN TRANS-GENIC MICE CARRYING THE HUMAN PROTOTYPE c-Ha-ras GENE
• Difference in the Types of Uterine Tumors between Heterozygous p53-deficient and Wild Type CBA Mice Treated with Ethinylestradiol after N-ethyl-N-nitrosourea Initiation
• Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
• 日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
• Twenty Novel Genetic Variations and Haplotype Structures of the DCK Gene Encoding Human Deoxycytidine Kinase (dCK)
• Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
• Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
• Fourteen Novel Genetic Variations and Haplotype Structures of the TYMS Gene Encoding Human Thymidylate Synthase (TS)
• 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
• Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
• Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
• Genetic Polymorphisms of UGT1A6 in a Japanese Population
• Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
• Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days
• Three Novel Single Nucleotide Polymorphisms in UGT1A9
• Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
• Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
• Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
• Three novel single nucleotide polymorphisms in UGT1A10
• Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
• Clonal Analysis of Adenosquamous Carcinoma of the Lung
• GONADAL TOXICITY OF AN ETHANOL EXTRACT OF PSORALEA CORYLIFOLIA IN A RAT 90-DAY REPEATED DOSE STUDY
• The Utility of N-nitrosamines as Initiators for a 26-Week Rat Two-Stage Nasal Carcinogenesis Model
• Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
• Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells
• A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
• Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
• Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models
• Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo
• Reversal of Cisplatin Resistance by the 1,4-Benzothiazepine Derivative, JTV-519
• CPT-11 Alters the Circadian Rhythm of Dihydropyrimidine Dehydrogenase mRNA in Mouse Liver
• Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA-transfected Human Lung Cancer Cells
• Characterization of a Human Small-cell Lung Cancer Cell Line Resistant to a New Water-soluble Camptothecin Derivative, DX-8951f
• Preferential Binding of E7010 to Murine β3-Tubulin and Decreased β3-Tubulin in E7010-resistant Cell Lines
• In vitro Enhancement of Antitumor Activity of a Water-soluble Duocarmycin Derivative, KW-2189, by Caffeine-mediated DNA-repair Inhibition in Human Lung Cancer Cells
• p16^ Expression Is Associated with the Increased Sensitivity of Human Non-small Cell Lung Cancer Cells to DNA Topoisomerase I Inhibitors
• Interferon-γ-inducing Factor Gene Transfection into Lewis Lung Carcinoma Cells Reduces Tumorigenicity in vivo
• Effect of Glutathione Depletion on Cisplatin Resistance in Cancer Cells Transfected with the γ-Glutamylcysteine Synthetase Gene
• A Topoisomerase II Inhibitor, NK109, Induces DNA Single- and Double-strand Breaks and Apoptosis
• Effect of suramin on cdc2 kinase activity of the purified enzyme and from the crude extracts from lung cancer cells
• Correlation of Gene-specific Damage with Cisplatin between Human Adenocarcinoma Cells and Peripheral Blood Mononuclear Cells Analyzed by Polymerase Chain Reaction-stop Assay
• High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients
• A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
• Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors
• Enhancement of in vivo Antitumor Activity of a Novel Antimitotic 1-Phenylpropenone Derivative, AM-132, by Tumor Necrosis Factor-α or Interleukin-6
• Intracellular Carboxyl Esterase Activity Is a Determinant of Cellular Sensitivity to the Antineoplastic Agent KW-2189 in Cell Lines Resistant to Cisplatin and CPT-11
• The role of a common TNNT2 polymorphism in cardiac hypertrophy
• TIME COURSE OBSERVATION OF THYROID PROLIFERATIVE LESIONS AND SERUM LEVELS OF RELATED HORMONES IN RATS TREATED WITH KOJIC ACID AFTER DHPN INITIATION
• Immunotherapy by intra-peritoneal intra-peritoneal injection of interleukin-2 gene transduced ling cancer cell line.
• Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity
• Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non-small cell lung cancer patients
• What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
• Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan
• Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
• Tumor response to chemotherapy : The validity and reproducibility of RECIST guidelines in NSCLC patients
• INHIBITORY EFFECTS OF REPEATED INTRAVENOUS INJECTIONS OF DEXAMETHASONE ON PULMONARY TOXICITY OF A NEW MITOMYCIN C ANALOGUE, KW-2149, IN A NOVEL RAT MODEL
• Inhibitory effects of dexamethasone on pulmonary toxicity of a new mitomycin C analogue KW-2149 in a novel rat model.
• Prospective Evaluation of the Feasibility of Cisplatin-based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
• DOSE-THRESHOLD FOR THYROID TUMOR-PROMOTING EFFECTS OF ORALLY AMINISTERED KOJIC ACID IN RATS AFTER INITIATION WITH N-bis(2-HYDROXYPROPYL) NITROSAMINE
• ANTITUMOR ACTIVITY OF QUINOCARMYCIN AGAINST CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY
• Association between Smoking and Tumor Progression in Japanese Women with Adenocarcinoma of the Lung
• Microsatellite Instability in Lung Cancer Patients 40 Years of Age or Younger
• P-39 Effect of t-buthylhydroquinone and sodium nitrite alone or in combination on the forestomach of rasH2 mice.(Proceedings of the 27th Annual Meeting)
• 21B-04-1 Preliminary Repeated Dose (28 Days) Oral Toxicity Study of Flutamide to Establish the Efficacy of the "Enhanced OECD Test Guideline 407" in Rats.
• Absence of Tumor Promoting Activity of Xylazine in a Two-stage Nasal Carcinogenesis Model in N-bis(2-hydroxypropyl)nitrosamine-treated Rats
• P-67 Early changes of thyroid and in rats given a single administration of diisopropanolnitrosamine.(Proceedings of the 27th Annual Meeting)
• O-14 Mechanistic studies on testicular toxicity of Psoralea corylifolia extract in rats.(Proceedings of the 27th Annual Meeting)
• 21B-10-1 Triphenylboron compounds affect both lymphoid and hematopoietic organs in rats.
• Enhanced Anti-tumor Effect of Trastuzumab in Combination with Cisplatin
• Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)
• Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
• A case of sarcomatoid carcinoma of the thymus
• MECHANISM OF FK506-INDUCED GLUCOSE INTOLERANCE IN RATS
• COMPARATIVE STUDIES OF PULSE AND CONTINUOUS EXPOSURE IN HUMAN TUMOR CLONOGENIC ASSAY
• THE USE OF HUMAN TUMOR CLONOGENIC ASSAY IN PREDICTING COMBINATION EFFECT OF CISPLATIN PLUS VINDESINE IN CARCINOMA OF THE LUNG
• Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
• Translational and clinical studies of target-based cancer therapy
• Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors
• P7-07 Is emulsification of the test substance with Freund's complete adjuvant(FCA) necessary in the guinea pig maximization test?(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION
• EFFECTS OF pH AND OSMOLALITY ON PHLEBITIC POTENTIAL OF INFUSION SOLUTIONS FOR PERIPHERAL PARENTERAL NUTRITION
• Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
• IN VITRO CHEMOSENSITIVITY PATTERNS OF CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY
• A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
• Genetic Polymorphisms of FCGRT Encoding FcRn in a Japanese Population and Their Functional Analysis
• "P-1 Effects of pH and Osmolality on Phlebitic Potential of infusion Solutions for Peripheral Parenteral Nutrition.
• Innovator and generic cisplatin formulations : Comparison of renal toxicity

もっと見る 閉じる

スポンサーリンク